Buscar
Mostrando ítems 1-5 de 5
Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt–Koyanagi–Harada disease: an updated review
(2022)
Vogt-Koyanagi-Harada (VKH) disease is a primary autoimmune stromal choroiditis. This review aimed to provide a novel perspective of the disease. We took into account recent developments in the understanding of the disease ...
Vogt-Koyanagi-Harada disease: the stepby-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review
(2022)
Background: Appraisals of Vogt-Koyanagi-Harada disease (VKH) have become progressively more complete, since its first description in 1906. The availability of new investigational methods has improved our knowledge of the ...
Adalimumab, therapeutic alternative in the Vogt Koyanagi Harada syndrome refractory to infliximab: case reportAdalimumab como alternativa terapéutica en el síndrome de Vogt Koyanagi Harada refractario al infliximab: reporte de caso
(Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana, 2016)
Injeção intravítrea de acetato de triancinolona no tratamento da síndrome de Vogt-Koyanagi-Harada
(Conselho Brasileiro de Oftalmologia, 2004-06-01)
PURPOSE: To report the use of intravitreal injection of triamcinolone acetonide in the acute phase of Vogt-Koyanagi-Harada's disease. METHODS: Nine eyes from five patients in the acute phase of Vogt-Koyanagi-Harada's disease ...
New insights into Vogt-Koyanagi-Harada disease
(Conselho Brasileiro de Oftalmologia, 2009)
Vogt-Koyanagi-Harada disease (VKH), a well-established multiorgan disorder affecting pigmented structures, is an autoimmune disorder of melanocyte proteins in genetically susceptible individuals. Several clinical and ...